These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 33650709

  • 21. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO, Seo JW, Kwon O, Park SM, Kim CH, Kim IH.
    Enzyme Microb Technol; 2012 Mar 10; 50(3):173-80. PubMed ID: 22305172
    [Abstract] [Full Text] [Related]

  • 22. Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein.
    Zanotto C, Pozzi E, Pacchioni S, Bissa M, De Giuli Morghen C, Radaelli A.
    J Transl Med; 2011 Nov 04; 9():190. PubMed ID: 22053827
    [Abstract] [Full Text] [Related]

  • 23. Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.
    Maclean J, Koekemoer M, Olivier AJ, Stewart D, Hitzeroth II, Rademacher T, Fischer R, Williamson AL, Rybicki EP.
    J Gen Virol; 2007 May 04; 88(Pt 5):1460-1469. PubMed ID: 17412974
    [Abstract] [Full Text] [Related]

  • 24. A CRR2-Dependent sRNA Sequence Supports Papillomavirus Vaccine Expression in Tobacco Chloroplasts.
    Legen J, Dühnen S, Gauert A, Götz M, Schmitz-Linneweber C.
    Metabolites; 2023 Feb 21; 13(3):. PubMed ID: 36984756
    [Abstract] [Full Text] [Related]

  • 25. Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris.
    Bazan SB, de Alencar Muniz Chaves A, Aires KA, Cianciarullo AM, Garcea RL, Ho PL.
    Arch Virol; 2009 Feb 21; 154(10):1609-17. PubMed ID: 19756360
    [Abstract] [Full Text] [Related]

  • 26. Production of immunogenic human papillomavirus-16 major capsid protein derived virus like particles.
    Patel MC, Patkar KK, Basu A, Mohandas KM, Mukhopadhyaya R.
    Indian J Med Res; 2009 Sep 21; 130(3):213-8. PubMed ID: 19901429
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity.
    Schädlich L, Senger T, Gerlach B, Mücke N, Klein C, Bravo IG, Müller M, Gissmann L.
    J Virol; 2009 Aug 21; 83(15):7690-705. PubMed ID: 19457985
    [Abstract] [Full Text] [Related]

  • 29. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers.
    Zhao X, Fay J, Lambkin H, Schwartz S.
    Virology; 2007 Dec 20; 369(2):351-63. PubMed ID: 17869320
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae.
    Kim HJ, Lee SJ, Kim HJ.
    J Biotechnol; 2010 Oct 01; 150(1):31-6. PubMed ID: 20696192
    [Abstract] [Full Text] [Related]

  • 32. Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly.
    Kuck D, Leder C, Kern A, Müller M, Piuko K, Gissmann L, Kleinschmidt JA.
    Vaccine; 2006 Apr 05; 24(15):2952-65. PubMed ID: 16414157
    [Abstract] [Full Text] [Related]

  • 33. Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity.
    Schädlich L, Senger T, Kirschning CJ, Müller M, Gissmann L.
    Vaccine; 2009 Mar 04; 27(10):1511-22. PubMed ID: 19174177
    [Abstract] [Full Text] [Related]

  • 34. Transfer of transformed chloroplasts from Nicotiana tabacum to the Lycium barbarum plants.
    Sytnik E, Komarnytsky I, Gleba Y, Kuchuk N.
    Cell Biol Int; 2005 Jan 04; 29(1):71-5. PubMed ID: 15763502
    [Abstract] [Full Text] [Related]

  • 35. An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins.
    Windram OP, Weber B, Jaffer MA, Rybicki EP, Shepherd DN, Varsani A.
    Arch Virol; 2008 Jan 04; 153(3):585-9. PubMed ID: 18175039
    [Abstract] [Full Text] [Related]

  • 36. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A, Candeias JMG, Thomann P, Villa LL, Franco EL, Trottier H, The Ludwig-McGill Study Group.
    J Med Microbiol; 2020 Jul 04; 69(7):960-970. PubMed ID: 32510304
    [Abstract] [Full Text] [Related]

  • 37. Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods.
    Matić S, Masenga V, Poli A, Rinaldi R, Milne RG, Vecchiati M, Noris E.
    Plant Biotechnol J; 2012 May 04; 10(4):410-21. PubMed ID: 22260326
    [Abstract] [Full Text] [Related]

  • 38. HPV16 L2 improves HPV16 L1 gene delivery as an important approach for vaccine design against cervical cancer.
    Namvar A, Bolhassani A, Hashemi M.
    Bratisl Lek Listy; 2016 May 04; 117(3):179-84. PubMed ID: 26925750
    [Abstract] [Full Text] [Related]

  • 39. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.
    Bellone S, El-Sahwi K, Cocco E, Casagrande F, Cargnelutti M, Palmieri M, Bignotti E, Romani C, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
    J Virol; 2009 Jul 04; 83(13):6779-89. PubMed ID: 19386711
    [Abstract] [Full Text] [Related]

  • 40. Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants.
    Rosales-Mendoza S, Alpuche-Solís AG, Soria-Guerra RE, Moreno-Fierros L, Martínez-González L, Herrera-Díaz A, Korban SS.
    Plant J; 2009 Jan 04; 57(1):45-54. PubMed ID: 18764920
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.